- Home
- NMRA vs AFRI Comparison
NMRA vs AFRI Comparison
Compare NMRA & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- AFRI
- Stock Information
- Founded
- NMRA 2019
- AFRI 1943
- Country
- NMRA United States
- AFRI Gibraltar
- Employees
- NMRA N/A
- AFRI N/A
- Industry
- NMRA
- AFRI Packaged Foods
- Sector
- NMRA
- AFRI Consumer Staples
- Exchange
- NMRA Nasdaq
- AFRI Nasdaq
- Market Cap
- NMRA 287.6M
- AFRI 275.5M
- IPO Year
- NMRA 2023
- AFRI N/A
- Fundamental
- Price
- NMRA $1.13
- AFRI $8.44
- Analyst Decision
- NMRA Buy
- AFRI
- Analyst Count
- NMRA 8
- AFRI 0
- Target Price
- NMRA $10.14
- AFRI N/A
- AVG Volume (30 Days)
- NMRA 1.3M
- AFRI 17.1K
- Earning Date
- NMRA 03-03-2025
- AFRI 04-30-2025
- Dividend Yield
- NMRA N/A
- AFRI N/A
- EPS Growth
- NMRA N/A
- AFRI N/A
- EPS
- NMRA N/A
- AFRI N/A
- Revenue
- NMRA N/A
- AFRI $325,098,000.00
- Revenue This Year
- NMRA N/A
- AFRI N/A
- Revenue Next Year
- NMRA N/A
- AFRI N/A
- P/E Ratio
- NMRA N/A
- AFRI N/A
- Revenue Growth
- NMRA N/A
- AFRI 15.94
- 52 Week Low
- NMRA $1.13
- AFRI $8.18
- 52 Week High
- NMRA $17.19
- AFRI $12.00
- Technical
- Relative Strength Index (RSI)
- NMRA 26.07
- AFRI 31.78
- Support Level
- NMRA $1.13
- AFRI $8.10
- Resistance Level
- NMRA $1.23
- AFRI $9.00
- Average True Range (ATR)
- NMRA 0.12
- AFRI 0.39
- MACD
- NMRA 0.05
- AFRI -0.00
- Stochastic Oscillator
- NMRA 3.54
- AFRI 31.78
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.